Given the unexpected finding that subtype2 with high PBRM1 mutation rate was not related to proportion of CD8 T cell, we investigated whether tumor intrinsic features affect the response to ICIs within the context of different immune subtypes. The gene discussed is PBRM1; the disease is neoplasm.